KV Pharmaceutical Enters Consent Decree With FDA In Move To Resume Manufacturing
This article was originally published in The Pink Sheet Daily
Executive Summary
Certain products will not be distributed until approved via NDA or ANDA processes.
You may also be interested in...
KV Pharmaceutical Cleared To Resume Some Drug Shipments, But Cash Crisis Looms
FDA gives go-ahead for the beleaguered company to ship two potassium chloride formulations following a satisfactory GMP inspection in August.
KV Pharmaceutical Cleared To Resume Some Drug Shipments, But Cash Crisis Looms
FDA gives go-ahead for the beleaguered company to ship two potassium chloride formulations following a satisfactory GMP inspection in August.
Gestiva Approval Unlikely In FY 09; KV Pharmaceutical Admits Credit Fumbles
Firm halts manufacturing and distribution of nearly all products.